Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America

By P. Pappas, C. Kauffman, D. Andes, Daniel K. Benjamin, Thierry Calandra, J. Edwards, S. Filler, J. Fisher, B. Kullberg, L. Ostrosky-Zeichner and 4 more. Clinical Infectious Diseases, 2009

3,078 citations recorded by the source corpus.

Guidelines for the management of patients with invasive candidiasis and mucosal candidiasis were prepared by an Expert Panel of the Infectious Diseases Society of America. These updated guidelines replace the previous guidelines published in the 15 January 2004 issue of Clinical Infectious Diseases and are intended for use by health care providers who care for patients who either have or are at risk of these infections. Since 2004, several new antifungal agents have become available, and several new studies have been published relating to the treatment of candidemia, other forms of invasive candidiasis, and mucosal disease, including oropharyngeal and esophageal candidiasis. There are also recent prospective data on the prevention of invasive candidiasis in high-risk neonates and adults and on the empiric treatment of suspected invasive candidiasis in adults. This new information is incorporated into this revised document.

Subfields: Epidemiology, Infectious Diseases, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/43a6508958d3f1cf82a877e1de2027ab64c2fb8b

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

In Infectious Diseases

In Pulmonary and Respiratory Medicine

Citations in the corpus

Candida Infections of the Genitourinary Tract (2010, background): “Several topical and oral drugs are available, without evidence for superiority of any agent or route of administration (189), although among the topically applied drugs, azoles are more effective than nystatin (287).”
Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. (2010, background): “Recommendations for the management of fungal UTI are provided in the Infectious Disease Society of America’s (IDSA) treatment guidelines for candidiasis [1].”
Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations. (2013, background): “for candidemia [1] and the prevailing attitude is that given the safety and potency of the echinocandins, any increase in nonalbicans Candida species and associated resistance to FLC is”
Epidemiology of Invasive Mycoses in North America (2010, background): “is vital to have knowledge of local epidemiologic trends in order to guide initial therapy for Candida BSI (Kollef et al. 2008; Pappas et al. 2009; Riddell et al. 2008; Rijnders et al. 2000).”
Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America (2009, background): “Management of candidemia and other fungal infections is summarized in table 5 and figures 2–4, and in the recent IDSA guidelines for the management of candidiasis [201].”
Common oral complications of head and neck cancer radiation therapy: mucositis, infections, saliva change, fibrosis, sensory dysfunctions, dental caries, periodontal disease, and osteoradionecrosis (2017, background): “Fluconazole can be used for prophylaxis in cases with frequent recurrences using 50–200 mg/day or 100–400 mg/week, and has been shown superior to oral polyenes [32].”
Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-Year Analysis of Susceptibilities of Candida Species to Fluconazole and Voriconazole as Determined by CLSI Standardized Disk Diffusion (2010, background): “These and other relatively rare species of Candida are unlikely to be familiar to many clinicians and microbiologists, and there are few or no data concerning prognosis or optimal treatment strategies (13, 14, 25, 41, 43, 47, 53, 54, 65, 66).”
Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America. (2014, background): “” Rather, recommendations for these infections are extrapolated from broad group guidelines that include references to SSTIs and have been developed by professional organizations including IDSA, the National Comprehensive Cancer Network (NCCN), American Society of Blood and Marrow Transplantation, t”
ESCMID guideline for the diagnosis and treatment of biofilm infections 2014. (2015, background): “because non-removal is associated with an increased mortality and a more prolonged candidaemia [16,102,162,175–182].”